Article The proteogenomic subtypes of acute leukemia

被引:70
作者
Jayavelu, Ashok Kumar [1 ,5 ,6 ,30 ]
Wolf, Sebastian [2 ,27 ]
Buettner, Florian [3 ,4 ,7 ,27 ]
Alexe, Gabriela [8 ,9 ]
Haeupl, Bjoern [2 ,3 ,4 ,27 ]
Comoglio, Federico [10 ]
Schneider, Constanze [2 ]
Doebele, Carmen [2 ,3 ,4 ]
Fuhrmann, Dominik C. [11 ]
Wagner, Sebastian [2 ]
Donato, Elisa [12 ,13 ,14 ]
Andresen, Carolin [12 ,13 ,14 ]
Wilke, Anne C. [2 ]
Zindel, Alena [2 ,3 ,4 ]
Jahn, Dominique [2 ,3 ,4 ]
Splettstoesser, Bianca [1 ]
Plessmann, Uwe [15 ]
Muench, Silvia [2 ]
Abou-El-Ardat, Khali [2 ]
Makowka, Philipp [2 ]
Acker, Fabian [2 ]
Enssle, Julius C. [2 ]
Cremer, Anjali [2 ]
Schnutgen, Frank [2 ,3 ,4 ,27 ]
Kurrle, Nina [2 ,3 ,4 ,27 ]
Chapuy, Bjoern [16 ,28 ]
Loeber, Jens [16 ,28 ]
Hartmann, Sylvia [17 ]
Wild, Peter J. [17 ]
Wittig, Ilka [18 ]
Huebschmann, Daniel [4 ,12 ,13 ,14 ,19 ,20 ]
Kaderali, Lars [21 ]
Cox, Juergen [22 ]
Bruene, Bernhard [11 ]
Roellig, Christoph [23 ]
Thiede, Christian [23 ]
Steffen, Bjoern [2 ]
Bornhaeuser, Martin [23 ,24 ]
Trumpp, Andreas [12 ,13 ,14 ,29 ]
Urlaub, Henning [15 ,25 ]
Stegmaier, Kimberly [8 ,9 ,26 ]
Serve, Hubert [2 ,3 ,4 ,27 ]
Mann, Matthias [1 ]
Oellerich, Thomas [2 ,3 ,4 ,27 ]
机构
[1] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Martinsried, Germany
[2] Univ Hosp Frankfurt, Goethe Univ, Dept Med 2, Hematol Oncol, Theodor Stern Kai 7, Frankfurt, Germany
[3] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] DKFZ, Clin Cooperat Unit Pediat Leukemia, Heidelberg, Germany
[6] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[7] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Frankfurt, Germany
[8] Dana Farber Canc Inst, Dept Pediat Oncol, Div Hematol Oncol, Boston, MA 02115 USA
[9] Boston Childrens Hosp, Boston, MA USA
[10] enGene Stat GmbH, Basel, Switzerland
[11] Goethe Univ, Dept Biochem 1, Frankfurt, Germany
[12] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany
[13] DKFZ ZMBH Alliance, Heidelberg, Germany
[14] Heidelberg Inst Stem Cell Technol & Expt Med HIST, Heidelberg, Germany
[15] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Gottingen, Germany
[16] Univ Med Ctr Gottingen, Dept Med Hematol & Oncol, Gottingen, Germany
[17] Univ Hosp Frankfurt, Dr Senckenberg Inst Pathol, Frankfurt, Germany
[18] Goethe Univ, Inst Cardiovasc Physiol, Funct Prote, Frankfurt, Germany
[19] Heidelberg Inst Stem Cell Technol & Expt Med HIST, Pattern Recognit & Digital Med, Heidelberg, Germany
[20] Natl Ctr Tumor Dis NCT Heidelberg, Mol Precis Oncol Program, Computat Oncol, Heidelberg, Germany
[21] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany
[22] Max Planck Inst Biochem, Computat Syst Biochem Res Grp, Martinsried, Germany
[23] Univ Hosp Carl Gustav Carus TU Dresden, Dept Internal Med 1, Dresden, Germany
[24] Dresden NCT UCC, Natl Ctr Tumor Dis, Dresden, Germany
[25] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt, Gottingen, Germany
[26] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[27] Goethe Univ Frankfurt, Frankfurt Canc Inst, Frankfurt, Germany
[28] Univ Med Berlin, Charite, Dept Hematol Oncol & Tumor Immunol, Campus Benjamin Franklin, Berlin, Germany
[29] German Canc Consortium DKTK, Heidelberg, Germany
[30] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany
关键词
ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; FUNCTIONAL PREDICTIONS; COMPUTATIONAL PLATFORM; DATABASE; PROTEIN; HETEROGENEITY; AML; CLASSIFICATION; IDENTIFICATION;
D O I
10.1016/j.ccell.2022.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a comprehensive proteogenomic analysis of bone marrow biopsies from 252 uniformly treated AML patients to elucidate the molecular pathophysiology of AML in order to inform future diagnostic and therapeutic approaches. In addition to in-depth quantitative proteomics, our analysis includes cytogenetic profiling and DNA/RNA sequencing. We identify five proteomic AML subtypes, each reflecting specific biological features spanning genomic boundaries. Two of these proteomic subtypes correlate with patient outcome, but none is exclusively associated with specific genomic aberrations. Remarkably, one subtype (Mito-AML), which is captured only in the proteome, is characterized by high expression of mitochondrial proteins and confers poor outcome, with reduced remission rate and shorter overall survival on treatment with intensive induction chemotherapy. Functional analyses reveal that Mito-AML is metabolically wired toward stronger complex I-dependent respiration and is more responsive to treatment with the BCL2 inhibitor venetoclax.
引用
收藏
页码:301 / +
页数:30
相关论文
共 97 条
  • [51] Kassambara A., 2021, SURVMINER DRAWING SU
  • [52] Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
    Ko, Myunggon
    An, Jungeun
    Bandukwala, Hozefa S.
    Chavez, Lukas
    Aijo, Tarmo
    Pastor, William A.
    Segal, Matthew F.
    Li, Huiming
    Koh, Kian Peng
    Lahdesmaki, Harri
    Hogan, Patrick G.
    Aravind, L.
    Rao, Anjana
    [J]. NATURE, 2013, 497 (7447) : 122 - +
  • [53] Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]
  • [54] Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
    Kuzelova, Katerina
    Brodska, Barbora
    Schetelig, Johannes
    Roelling, Christoph
    Racil, Zdenek
    Walz, Juliane Stickel
    Helbig, Grzegorz
    Fuchs, Ota
    Vrana, Milena
    Pecherkova, Pavla
    Salek, Cyril
    Mayer, Jiri
    [J]. PLOS ONE, 2018, 13 (12):
  • [55] Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens
    Lachowiez, Curtis A.
    Loghavi, Sanam
    Kadia, Tapan M.
    Daver, Naval
    Borthakur, Gautam
    Pemmaraju, Naveen
    Naqvi, Kiran
    Alvarado, Yesid
    Yilmaz, Musa
    Short, Nicholas
    Ohanian, Maro
    Pierce, Sherry R.
    Patel, Keyur P.
    Qiao, Wei
    Ning, Jing
    Sasaki, Koji
    Takahashi, Koichi
    Jabbour, Elias
    Andreeff, Michael
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Konopleva, Marina
    DiNardo, Courtney D.
    [J]. BLOOD ADVANCES, 2020, 4 (07) : 1311 - 1320
  • [56] The Human Transcription Factors
    Lambert, Samuel A.
    Jolma, Arttu
    Campitelli, Laura F.
    Das, Pratyush K.
    Yin, Yimeng
    Albu, Mihai
    Chen, Xiaoting
    Taipale, Jussi
    Hughes, Timothy R.
    Weirauch, Matthew T.
    [J]. CELL, 2018, 172 (04) : 650 - 665
  • [57] ClinVar: public archive of interpretations of clinically relevant variants
    Landrum, Melissa J.
    Lee, Jennifer M.
    Benson, Mark
    Brown, Garth
    Chao, Chen
    Chitipiralla, Shanmuga
    Gu, Baoshan
    Hart, Jennifer
    Hoffman, Douglas
    Hoover, Jeffrey
    Jang, Wonhee
    Katz, Kenneth
    Ovetsky, Michael
    Riley, George
    Sethi, Amanjeev
    Tully, Ray
    Villamarin-Salomon, Ricardo
    Rubinstein, Wendy
    Maglott, Donna R.
    [J]. NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) : D862 - D868
  • [58] Capturing heterogeneity in gene expression studies by surrogate variable analysis
    Leek, Jeffrey T.
    Storey, John D.
    [J]. PLOS GENETICS, 2007, 3 (09): : 1724 - 1735
  • [59] Quantitative Assessment of In-solution Digestion Efficiency Identifies Optimal Protocols for Unbiased Protein Analysis
    Leon, Ileana R.
    Schwammle, Veit
    Jensen, Ole N.
    Sprenger, Richard R.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2013, 12 (10) : 2992 - 3005
  • [60] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
    Ley, Timothy J.
    Miller, Christopher
    Ding, Li
    Raphael, Benjamin J.
    Mungall, Andrew J.
    Robertson, A. Gordon
    Hoadley, Katherine
    Triche, Timothy J., Jr.
    Laird, Peter W.
    Baty, Jack D.
    Fulton, Lucinda L.
    Fulton, Robert
    Heath, Sharon E.
    Kalicki-Veizer, Joelle
    Kandoth, Cyriac
    Klco, Jeffery M.
    Koboldt, Daniel C.
    Kanchi, Krishna-Latha
    Kulkarni, Shashikant
    Lamprecht, Tamara L.
    Larson, David E.
    Lin, Ling
    Lu, Charles
    McLellan, Michael D.
    McMichael, Joshua F.
    Payton, Jacqueline
    Schmidt, Heather
    Spencer, David H.
    Tomasson, Michael H.
    Wallis, John W.
    Wartman, Lukas D.
    Watson, Mark A.
    Welch, John
    Wendl, Michael C.
    Ally, Adrian
    Balasundaram, Miruna
    Birol, Inanc
    Butterfield, Yaron
    Chiu, Readman
    Chu, Andy
    Chuah, Eric
    Chun, Hye-Jung
    Corbett, Richard
    Dhalla, Noreen
    Guin, Ranabir
    He, An
    Hirst, Carrie
    Hirst, Martin
    Holt, Robert A.
    Jones, Steven
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) : 2059 - 2074